Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
EP08.01-018 - Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Impact of Local Therapy in Patients with Oligoprogression
Presenter: Cole Friedes | Author(s): Nikhil Yegya-Raman, Charu Aggarwal, Melina Elpi Marmarelis, Roger Cohen, William Levin, Keith Cengel, Christine Ciunci, John Kosteva, Aditi Singh, Kyle Robinson, Lova Sun, Christopher D'Avella, Christiana Davis, Corey J Langer, Steven Feigenberg- Abstract
Loading...
-
+
P1.10 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
-
+
P1.10-01 - Phase 3 Study of Durvalumab Combined with Oleclumab or Monalizumab in Patients with Unresectable Stage III NSCLC (PACIFIC-9)
Presenter: Aarthi Gopinathan | Author(s): Fabrice Barlesi, Sarah B. Goldberg, Helen Mann, Michael Newton, Charu Aggarwal- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- 17:00 - 19:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
-
+
P1.15-07 - Phase II Study of Pembrolizumab and Itacitinib for First Line Treatment of Metastatic NSCLC Expressing PD-L1
Presenter: Melina Elpi Marmarelis | Author(s): Divij Mathew, Joshua M Bauml, Wei-Ting Hwang, Jane Zhang, Aditi Singh, Christopher D'Avella, Christiana Davis, Darwin Ye, Lova Sun, Christine Ciunci, Nancy Zhang, Charu Aggarwal, Roger Cohen, Andy Minn, E. John Wherry, Corey J Langer- Abstract
Loading...
-
+
ES24 - Palliative Care Integration and QOL in Advanced Lung Cancer
- 14:45 - 15:45
- 8/08/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Palliative and Supportive Care
- Moderators:Charu Aggarwal, Karin Dieckmann
-
+
Session Moderator
15:11 - 15:23 | Presenter: Charu Aggarwal
- Abstract
Loading... -
+
Session Moderator
15:11 - 15:23 | Presenter: Karin Dieckmann
- Abstract
Loading... -
+
ES24.01 - Session Introduction
14:45 - 14:46 | Presenter: Charu Aggarwal
- Abstract
Loading... -
+
ES24.02 - Session Introduction
14:46 - 14:47 | Presenter: Karin Dieckmann
- Abstract
Loading... -
+
ES24.03 - Early Palliative Care in Advanced Non-small-Cell Lung Cancer
14:47 - 14:59 | Presenter: Jennifer Temel
- Abstract
Loading... -
+
ES24.04 - Treatment Decision-Making for Patients with Complicated Bone Metastases
14:59 - 15:11 | Presenter: Thanyanan Baisamut
- Abstract
Loading... -
+
ES24.05 - What Is the Role of Supporting Care to Improve Checkpoint Inhibitor Tolerance?
15:11 - 15:23 | Presenter: Mirjana Rajer
- Abstract
Loading... -
+
ES24.06 - The Management of Pain in Lung Cancer: Pharmacological Interventions
15:23 - 15:35 | Presenter: Marliese Alexander
- Abstract
Loading... -
+
ES24.07 - Live Q&A
15:35 - 15:45
- Abstract
Loading...
